Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
Top Cited Papers
Open Access
- 1 June 2010
- journal article
- review article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (6) , 2560-2575
- https://doi.org/10.1210/jc.2009-2575
Abstract
Context: The risks of testosterone therapy in men remain poorly understood. Objective: The aim of this study was to conduct a systematic review and meta-analyses of testosterone trials to evaluate the adverse effects of testosterone treatment in men. Data Sources: We searched MEDLINE, EMBASE, and Cochrane CENTRAL from 2003 through August 2008. Review of reference lists and contact with experts further identified candidate studies. Study Selection: Eligible studies were comparative, randomized, and nonrandomized and reported the effects of testosterone on outcomes of interest (death, cardiovascular events and risk factors, prostate outcomes, and erythrocytosis). Reviewers, working independently and in duplicate, determined study eligibility. Data Extraction: Reviewers working independently and in duplicate determined the methodological quality of studies and collected descriptive, quality, and outcome data. Data Synthesis: The methodological quality of the 51 included studies varied from low to medium, and follow-up duration ranged from 3 months to 3 yr. Testosterone treatment was associated with a significant increase in hemoglobin [weighted mean difference (WMD), 0.80 g/dl; 95% confidence interval (CI), 0.45 to 1.14] and hematocrit (WMD, 3.18%; 95% CI, 1.35 to 5.01), and a decrease in high-density lipoprotein cholesterol (WMD, −0.49 mg/dl; 95% CI, −0.85 to −0.13). There was no significant effect on mortality, prostate, or cardiovascular outcomes. Conclusions: The adverse effects of testosterone therapy include an increase in hemoglobin and hematocrit and a small decrease in high-density lipoprotein cholesterol. These findings are of unknown clinical significance. Current evidence about the safety of testosterone treatment in men in terms of patient-important outcomes is of low quality and is hampered by the brief study follow-up.Keywords
This publication has 30 references indexed in Scilit:
- Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight lossAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation SystemJournal of Clinical Endocrinology & Metabolism, 2008
- Effect of testosterone therapy on lumbar spine and hip mineral density in elderly menThe Aging Male, 2008
- Effect of 2 Years of Testosterone Replacement on Insulin Secretion, Insulin Action, Glucose Effectiveness, Hepatic Insulin Clearance, and Postprandial Glucose Turnover in Elderly MenDiabetes Care, 2007
- Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual functionInternational Journal Of Impotence Research, 2007
- Androgen Treatment and Muscle Strength in Elderly Men: A Meta‐AnalysisJournal of the American Geriatrics Society, 2006
- Transdermal Androgen Therapy to Augment EPO in the Treatment of Anemia of Chronic Renal DiseaseAmerican Journal of Kidney Diseases, 2006
- Double‐blind placebo‐controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadismInternational Journal of Andrology, 2005
- Testosterone treatment for men with chronic heart failureHeart, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003